Item(by='timr', descendants=None, kids=[25800325], score=None, time=1610774720, title=None, item_type='comment', url=None, parent=25800137, text='The title of this post is utterly misleading. It should be corrected to reflect what the article actually says, which is that there is an elevated <i>biomarker</i>. A biomarker is not the same thing as &quot;damage&quot;. A direct quote from the article:<p>&gt; “We do not yet know the clinical implications of this elevated biomarker in children with COVID-19 and no symptoms or minimal symptoms,” said co-senior author David T. Teachey, MD<p>Moreover, the title of the release is clear:<p>&gt; CHOP Researchers Find Elevated Biomarker <i>Related to</i> Blood Vessel Damage<p>Edit: on reading the paper, they&#x27;re looking at a biomarker that is part of the complement system (C5b9), which is an ancient part of the human immune system, associated with <i>many</i> different illnesses. One of the reasons it activates is infection with viruses.<p><a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Complement_system" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Complement_system</a><p>Claiming that this is evidence of blood vessel damage is a <i>wild</i> leap to an unsupported conclusion. It&#x27;s a bit like saying that elevated a1c levels (i.e. a routine pre-diabetes marker) are evidence of organ damage.<p>Paper is here: <a href="https:&#x2F;&#x2F;ashpublications.org&#x2F;bloodadvances&#x2F;article&#x2F;4&#x2F;23&#x2F;6051&#x2F;474421&#x2F;Evidence-of-thrombotic-microangiopathy-in-children" rel="nofollow">https:&#x2F;&#x2F;ashpublications.org&#x2F;bloodadvances&#x2F;article&#x2F;4&#x2F;23&#x2F;6051&#x2F;...</a>')